Founded at BIDMC in 2009, Agios is the first major biopharmaceutical company focused on cancer metabolism.
A unique collaboration created in 2010 to accelerate the translation of biomedical research into new drugs and therapies.
Licensed from BIDMC, this test creates new opportunities for personalized effective management of renal graft patients.
If you are planning on working on industry sponsored research, TVO can help with the budget, the agreement and assist in managing the relationship.
If you are planning on discussing your research ideas and confidential information with a third party you may need a Confidentiality Agreement.